• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Examining valganciclovir prophylaxis duration among high-risk donor seropositive/recipient seronegative heart transplant recipients in a larger cohort.

作者信息

Imlay Hannah, Dumitriu Carcoana Allison O, Fisher Cynthia E, Wong Beatrice, Rakita Robert M, Fishbein Daniel P, Limaye Ajit P

机构信息

Division of Allergy and Infectious Diseases, Department of Internal Medicine, University of Washington, Seattle, WA, USA.

Division of Infectious Diseases, Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA.

出版信息

Transpl Infect Dis. 2021 Aug;23(4):e13581. doi: 10.1111/tid.13581. Epub 2021 Feb 18.

DOI:10.1111/tid.13581
PMID:33529417
Abstract
摘要

相似文献

1
Examining valganciclovir prophylaxis duration among high-risk donor seropositive/recipient seronegative heart transplant recipients in a larger cohort.
Transpl Infect Dis. 2021 Aug;23(4):e13581. doi: 10.1111/tid.13581. Epub 2021 Feb 18.
2
Impact of donor and recipient cytomegalovirus serology on long-term survival of heart transplant recipients.供体和受体巨细胞病毒血清学对心脏移植受者长期生存的影响。
Transpl Infect Dis. 2019 Feb;21(1):e13015. doi: 10.1111/tid.13015. Epub 2018 Nov 19.
3
Impact of valganciclovir prophylaxis duration on cytomegalovirus disease in high-risk donor seropositive/recipient seronegative heart transplant recipients.缬更昔洛韦预防疗程对高危供者血清阳性/受者血清阴性心脏移植受者巨细胞病毒病的影响。
Transpl Infect Dis. 2020 Jun;22(3):e13255. doi: 10.1111/tid.13255. Epub 2020 Feb 20.
4
Effects of oral valganciclovir prophylaxis for cytomegalovirus infection in heart transplant patients.口服缬更昔洛韦预防心脏移植患者巨细胞病毒感染的效果
Drug Des Devel Ther. 2012;6:289-95. doi: 10.2147/DDDT.S36578. Epub 2012 Oct 12.
5
Acyclovir versus valganciclovir for preventing cytomegalovirus infection in intermediate-risk liver transplant recipients.阿昔洛韦与缬更昔洛韦预防中危肝移植受者巨细胞病毒感染的比较
Prog Transplant. 2015 Mar;25(1):39-44. doi: 10.7182/pit2015558.
6
Effect of Preemptive Therapy vs Antiviral Prophylaxis on Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors: A Randomized Clinical Trial.抢先治疗与抗病毒预防对供体血清阳性受者血清阴性肝移植患者巨细胞病毒病的影响：一项随机临床试验。
JAMA. 2020 Apr 14;323(14):1378-1387. doi: 10.1001/jama.2020.3138.
7
Does valganciclovir hydrochloride (valcyte) provide effective prophylaxis against cytomegalovirus infection in liver transplant recipients?盐酸缬更昔洛韦（万赛维）对肝移植受者的巨细胞病毒感染有有效的预防作用吗？
Transplant Proc. 2005 Sep;37(7):3182-6. doi: 10.1016/j.transproceed.2005.07.032.
8
Cytomegalovirus disease among donor-positive/recipient-negative lung transplant recipients in the era of valganciclovir prophylaxis.更昔洛韦预防时代供者阳性/受者阴性肺移植受者中的巨细胞病毒病。
J Heart Lung Transplant. 2010 Sep;29(9):1014-20. doi: 10.1016/j.healun.2010.04.022. Epub 2010 Jul 3.
9
Increased incidence of cytomegalovirus infection in high-risk liver transplant recipients receiving valganciclovir prophylaxis versus ganciclovir prophylaxis.接受缬更昔洛韦预防治疗的高危肝移植受者与接受更昔洛韦预防治疗的高危肝移植受者相比，巨细胞病毒感染发生率增加。
Liver Transpl. 2009 Aug;15(8):963-7. doi: 10.1002/lt.21769.
10
Extending cytomegalovirus prophylaxis in high-risk (D+/R-) lung transplant recipients from 6 to 9 months reduces cytomegalovirus disease: A retrospective study.将高危（D+/R-）肺移植受者的巨细胞病毒预防时间从 6 个月延长至 9 个月可降低巨细胞病毒病：一项回顾性研究。
Transpl Infect Dis. 2020 Aug;22(4):e13277. doi: 10.1111/tid.13277. Epub 2020 Mar 27.

引用本文的文献

1
Incidence and severity of cytomegalovirus infection in seropositive heart transplant recipients.巨细胞病毒感染在血清阳性心脏移植受者中的发生率和严重程度。
Clin Transplant. 2023 Jun;37(6):e14982. doi: 10.1111/ctr.14982. Epub 2023 Mar 29.